ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,370, issued on April 21, was assigned to University of Cincinnati (Cincinnati).

"Agents and compositions for the treatment of glioblastoma" was invented by David Plas (Cincinnati) and Kelli Ennis (Cincinnati).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compositions including a combination of therapeutic agents comprising a therapeutically effective amount of merestinib and a therapeutically effective amount of LY2584702. Also provided herein are methods of treating glioblastomas in a subject by administering the disclosed compositions, as well as methods of inducing cell death in a PTEN-deficient glioblastoma cell by administe...